Clinical Trials in New York

Showing 18521-18540 of 22,668 trials

A Study of YM155 Plus Rituximab in Subjects With Non-Hodgkin's Lymphoma Who Have Received Prior Treatment

NCT01007292

The purpose of this study is to evaluate response rate, survival, safety and tolerability of YM155 given in combination with rituximab in subjects with Non-Hodgkin's Lymphoma.

Non-Hodgkin's Lymphoma

Astellas Pharma Inc43 participantsStarted Nov 2009

Columbus, Georgia, United States • Maywood, Illinois, United States • New York, New York, United States +16 more locations

COMPLETEDPhase 2< 1 mile

A Seven-Week Dose-Ranging Study of CP-526,555 Compared With Placebo and Zyban for Smoking Cessation

NCT00150241

The purpose of the study is to measure the safety and efficacy of three doses of varenicline for smoking cessation.

Smoking Cessation

Pfizer625 participantsStarted Feb 2000

Los Angeles, California, United States • Farmington, Connecticut, United States • Minneapolis, Minnesota, United States +4 more locations

A Study of YM155 Plus Rituximab in Subjects With Non-Hodgkin's Lymphoma Who Have Received Prior Treatment

A Seven-Week Dose-Ranging Study of CP-526,555 Compared With Placebo and Zyban for Smoking Cessation

Find Trials by Condition in New York

Veterans Affairs Lowering Readmission in Heart Failure

Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed or Refractory High-Risk NBL.

Safety and Efficacy of Aliskiren in Pediatric Hypertensive Patients 6-17 Years of Age

Investigation of the Superiority Effect of Orally Disintegrating Desmopressin Tablets to Placebo in Terms of Night Voids Reduction in Nocturia Adult Male Patients

The Valve of Hyaluronic Binding Selection (PICSI) in Improving IVF Outcome

Pemetrexed or Docetaxel With or Without Erlotinib in Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

A Phase II Study of MDX-060 in Subjects With Relapsed or Refractory Hodgkin's Disease

Phase II, 2nd Line Melanoma - RAND Monotherapy

Pioglitazone in Early Parkinson's Disease

Gabapentin For the Control of Hot Flashes in Women With Breast Cancer

Comparison of Antiemetic Drugs in Preventing Delayed Nausea After Chemotherapy in Patients With Cancer

Safety and Tolerability of Initiating LCZ696 in Heart Failure Patients

Effect of Intravesical Lidocaine on Urodynamic and Symptomatic Parameters of Interstitial Cystitis

Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder

Brain Metastases In ErbB2-Positive Breast Cancer

Study to Examine the Effect of Betahistine on Body Weight Gain Due to Olanzapine Treatment

Study to Assess the Effect of BMS-790052 on the Pharmacokinetics of Ortho Tri-Cyclen® in Healthy Female Subjects